# The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose

> **NCT00114855** · NA · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 40 (—)

## Conditions studied

- Hyperlipidemia
- Glucose Metabolism Disorders

## Interventions

- **DRUG:** HYPOCOL®

## Key facts

- **NCT ID:** NCT00114855
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-12
- **Final completion:** 2006-06
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-07-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114855, "The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00114855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*